Biomedical Engineering Reference
In-Depth Information
adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin
Invest 104(1):21-29
22. Shah AS, White DC, Emani S, Kypson AP, Lilly RE, Wilson K, Glower DD, Lefkowitz RJ,
Koch WJ (2001) In vivo ventricular gene delivery of a beta-adrenergic receptor kinase
inhibitor to the failing heart reverses cardiac dysfunction. Circulation 103(9):1311-1316
23. Hammond HK (2006) Adenylyl cyclase gene transfer in heart failure. Ann N Y Acad Sci
1080:426-436
24. Houser SR, Margulies KB (2003) Is depressed myocyte contractility centrally involved in
heart failure? Circ Res 92(4):350-358
25. Kawase Y, Ladage D, Hajjar RJ (2011) Rescuing the failing heart by targeted gene transfer.
J Am Coll Cardiol 57(10):1169-1180
26. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R,
Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T,
Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: phase I
assessment of direct intramyocardial administration of an adenovirus vector expressing
VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Circulation 100(5):468-474
27. Hedman M, Hartikainen J, Yla-Herttuala S (2011) Progress and prospects: hurdles to
cardiovascular gene therapy clinical trials. Gene Ther 18(8):743-749
28. Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y,
Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R,
Mancini D, Jessup M (2008) Design of a phase 1/2 trial of intracoronary administration of
AAV1/SERCA2a in patients with heart failure. J Card Fail 14(5):355-367
29. Rapti K, Chaanine AH, Hajjar RJ (2011) Targeted gene therapy for the treatment of heart
failure. Can J Cardiol 27(3):265-283
30. Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, West A, Rade JJ,
Marrott P, Hammond HK, Engler RL (2002) Angiogenic Gene Therapy (AGENT) in trial
patients with stable angina pectoris. Circulation 105(11):1291-1297
31. Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C,
Kleiman N (2003) Angiogene GENe Therapy (AGENT-2) Study Group.: A randomized,
double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on
myocardial perfusion in patients with stable angina. J Am Coll Cardiol 42(8):1339-1347
32. Henry TD, Grines CL, Watkins MW, Dib N, Barbeau G, Moreadith R, Andrasfay T, Engler RL
(2007) Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the
AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 50(11):1038-1046
33. Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A, Vanninen E,
Mussalo H, Kauppila E, Simula S, Narvanen O, Rantala A, Peuhkurinen K, Nieminen MS,
Laakso M, Yla-Herttuala S (2003) Safety and feasibility of catheter-based local
intracoronary vascular endothelial growth factor gene transfer in the prevention of
postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia:
phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107(21):2677-2683
34. Hedman M, Muona K, Hedman A, Kivela A, Syvanne M, Eranen J, Rantala A, Stjernvall J,
Nieminen MS, Hartikainen J, Yla-Herttuala S (2009) Eight-year safety follow-up of
coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Ther
16(5):629-634
35. Kastrup J, Jorgensen E, Ruck A, Tagil K, Glogar D, Ruzyllo W, Botker HE, Dudek D,
Drvota V, Hesse B, Thuesen L, Blomberg P, Gyongyosi M, Sylven C (2005) Euroinject One
Group.: Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene
therapy in patients with stable severe angina pectoris A randomized double-blind placebo-
controlled study: the Euroinject One trial. J Am Coll Cardiol 45(7):982-988
36. Stewart DJ, Kutryk MJ, Fitchett D, Freeman M, Camack N, Su Y, Della Siega A, Bilodeau L,
Burton JR, Proulx G, Radhakrishnan S (2009) NORTHERN Trial Investigators.: VEGF gene
therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary
disease: results of the NORTHERN trial. Mol Ther 17(6):1109-1115
